4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-058977
Options or other derivatives
- Chief Financial Officer acquired 187,582 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Alam Kamran Chief Financial Officer | 2023-12-14 | Grant or award · Employee Stock Option (right to buy) | +187,582 | 187,582 | D | ||
Loading xslF345X05/doc4.xml…